Contineum Therapeutics, Inc. (CTNM)
(Delayed Data from NSDQ)
$11.88 USD
-0.28 (-2.30%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $11.88 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CTNM 11.88 -0.28(-2.30%)
Will CTNM be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CTNM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CTNM
Wall Street Analysts Think Contineum Therapeutics, Inc. (CTNM) Could Surge 235.81%: Read This Before Placing a Bet
CTNM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CTNM
Doji - Bearish? appears for CTNM after 0.0% move
Is CTNM poised for gains? Crossed Above 20 Day Moving Average shows up after surging 6.76%
20 Day Moving Average Resistance appears for CTNM after 2.8% move
20 Day Moving Average Resistance appears for CTNM after 2.38% move
1,2,3 Pullback Bullish appears for CTNM after 5.58% move